RxDoctor Payments Data

Jonathan Gentile, MD

Pain Medicine · Carmel, INNPI 1558456020

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (50.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Zimmer Biomet at 50.5% of the total. Reporting peaked in 2021 at $2,691 and has fallen 87.0% since, to $350 in 2025.

$9,125in general payments, 2019–2025

Across 84 payments — averaging $108.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$5K
  • MML US, Inc.$2K
  • Medtronic$729
  • Relievant Medsystems, Inc.$535
  • Stryker$533
  • Vertos Medical, Inc.$416
  • plus $361 from 6 others
$1,117,535in research payments, 2019–2025

Across 61 payments — averaging $18,320 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • MML US, Inc.$1.1M

What the payments were for

  • Travel & lodging$1,26114%
  • Food & beverage$3,25636%
  • Education$4,60850%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,125 in reported general payments places this provider in the 75th percentile of 128 pain medicine providers in Indiana.

See all pain medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$161,747
Medicare patients
404
Services billed
6,409

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium63$730
Gabapentin46$538
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen44$488
Tramadol Hcl57$266
Methylprednisolone30$234
Cyclobenzaprine Hcl26$215
Celecoxib16$196
Lorazepam12$7

Paid to pharmacies, not to this prescriber.

Other pain medicine in Carmel

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →